No admission of liability. The receipt disagrees.
Abbott says the $670 million settlement over its premature-infant formula is not an admission of liability. The receipt says otherwise.
Source article: Abbott to pay $670 million to settle premature-infant formula cases.
Column metadata
- Published
- Pen name
- Editorial Board
- Topic tags
- consumer goods, health, health treatment and procedure, law, public health
- Storylines
- trump-health-policy-rfk
- Primary entities
- Abbott Laboratories, Gill lawsuit
- Themes
- corporate accountability, product liability litigation, infant formula safety
- Floor values engaged
- human_life_and_dignity, Accountability of power, Equality & fairness